돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2084579생성일: 2026년 10월 25일

Water → 2,5-Diamino-4,6-dichloropyrimidine

https://huagongshe.com/reaction/2084579

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물1,2,3-TrichloropropaneHCID 7285—
반응물HexaneHCID 8058—
반응물Sodium HydroxideHCID 14798—
반응물Phosphorus oxychlorideHCID 24813—
반응물HCID 178479162HCID 178479162—
촉매Tetramethylammonium chlorideHCID 6379—
용매TetrahydrofuranHCID 8028—
용매Ethyl AcetateHCID 8857—
생성물2,5-Diamino-4,6-dichloropyrimidineHCID 30103965%

반응 조건

온도115 °C

반응 단계

2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride (0.14 mol, 25 g) was filled into a dry reactor. Dry 1,2,3-trichloropropane (51.96 ml) was then added and the whole was stirred. Subsequently, tetra-methylammonium chloride (0.29 mol, 31.25 g) and then POCl3 (0.54-0.81 mol, 124.9−83.28 g, 50.6-75.9 ml) were added. The reaction was heated at reflux temperature (about 115° C.) for 24 h. The reaction was then cooled to below 50° C., ice water (24.44 mol, 440.44 g) was added and the whole was kept below 55° C. Subsequently, the reaction was adjusted to a pH of between 6.5 and 7.0 using 50% strength NaOH (3.12 mol, 124.92 g, 163.3 ml) and the temperature was kept below 55° C. The reaction was stirred at between 50 and 60° C. for 30 min. Tetrahydrofuran (3.7 mol, 267.0 g, 300 ml) was then added. In order to remove undesired material, the whole mixture was filtered through Celite and the filter cake was then washed with ethyl acetate (20.5 mol, 1806.58 g, 2002.86 ml) for subsequent extraction. The organic phase (tetrahydrofuran and ethyl acetate) was washed 3 times with water (5.57 mol, 100.32 g, 100.32 l), dried over NaHCO3 and filtered. Ethyl acetate was removed by vacuum distillation. Hexane (0.77 mol, 66.14 g, 100.36 ml) was then added to the residual organic material, and the whole was cooled to below 10° C., filtered and then dried at 50° C. in vacuo. The title product (0.09 mol, 15.71 g) was obtained as a slightly brownish solid, corresponding to a yield of about 65% based on 2,5-diamino-4,6-dihydroxypyrimidine employed.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06716981B2
출처 데이터셋uspto-grants-2004_04
ORD IDord-9740d0888f804f079cbb427cdd97d183
출처 메모uspto-grants-2004_04